Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases

Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases

Stem cell therapy is a promising alternative approach to heart diseases. The most prevalent source of multipotent stem cells, usually called somatic or adult stem cells (mesenchymal stromal/stem cells, MSCs) used in clinical trials is bone marrow (BM-MSCs), adipose tissue (AT-MSCs), umbilical cord (...

Full description

Bibliographic Details
Main Authors: Fernanda Gubert, Jaqueline Soares da Silva, Juliana F. Vasques, Renata Guedes de Jesus Gonçalves, Robertta Silva Martins, Mauro Paes Leme de Sá, Rosalia Mendez-Otero, Gisele Zapata-Sudo
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
mesenchymal stem cells
cardiac fibrosis
cardiovascular diseases
Online Access:https://www.mdpi.com/1422-0067/22/14/7447

Similar Items

Similar Items